Diagnostic Yield of Epilepsy Panels in Children With Medication-Refractory Epilepsy

Pediatric Neurology

Volumn 64, Issue , 2016, Pages 66-71

  Segal, Eric ^a   Pedro, Helio ^b   Valdez Gonzalez, Karen ^b   Parisotto, Sarah ^b   Gliksman, Felicia ^b   Thompson, Stephen ^b   Sabri, Jomard ^a   Fertig, Evan ^a  

^a Northeast Regional Epilepsy Group   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

children; epilepsy; gene panel; next generation sequencing

Indexed keywords

LACOSAMIDE; METHYL CPG BINDING PROTEIN 2; SODIUM CHANNEL NAV1.1; TUBERIN;

ANTICONVULSANT THERAPY; ARTICLE; AUTISM; CHILD; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC VALUE; DLG3 GENE; DRUG RESISTANT EPILEPSY; FRAMESHIFT MUTATION; GENE; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; MEDICAL RECORD REVIEW; MICROARRAY ANALYSIS; MISSENSE MUTATION; NEXT GENERATION SEQUENCING; PCDH19 GENE; PRIORITY JOURNAL; SEVERE MYOCLONIC EPILEPSY IN INFANCY; SLC9A6 GENE; ADOLESCENT; FEMALE; GENETIC SCREENING; GENETICS; HIGH THROUGHPUT SEQUENCING; MALE; NEWBORN; PRESCHOOL CHILD; RETROSPECTIVE STUDY;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; COMPARATIVE GENOMIC HYBRIDIZATION; DRUG RESISTANT EPILEPSY; FEMALE; GENETIC TESTING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; INFANT; INFANT, NEWBORN; MALE; MICROARRAY ANALYSIS; RETROSPECTIVE STUDIES;

EID: 84992195144     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2016.06.019     Document Type: Article

References (12)

1. 1 Kwan, P., Brodie, M.J., Early identification of refractory epilepsy. N Engl J Med 342 (2000), 314–319.
2. 2 Pong, A.W., Pal, D.K., Chung, W.K., Developments in molecular genetic diagnostics: an update for the pediatric epilepsy specialist. Pediatr Neurol 44 (2011), 317–327.
3. 3 Mercimek-Mahmutoglu, S., Patel, J., Cordeiro, D., et al. Diagnostic yield of genetic testing in epileptic encephalopathy in childhood. Epilepsia 56 (2015), 707–716.
4. 4 Lemke, J.R., Riesch, E., Scheurenbrand, et al. Targeted next generation sequencing as a diagnostic tool in epileptic disorders. Epilepsia 53 (2012), 1387–1398.
5. 5 Kwan, P., Arzimanoglou, A., Berg, A.T., et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51 (2010), 1069–1077.
6. 6 Berg, A.T., Berkovic, S.F., Brodie, M.J., et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009. Epilepsia 51 (2010), 676–685.
7. 7 Chiron, C., Dulac, O., The pharmacologic treatment of Dravet syndrome. Epilepsia 52:Suppl 2 (2011), 72–75.
8. 8 Dravet, C., The core Dravet syndrome phenotype. Epilepsia 52:Suppl 2 (2011), 3–9.
9. 9 Depienne, C., Bouteiller, D., Keren, B., et al. Sporadic infantile epileptic encephalopathy caused by mutations in PCDH19 resembles Dravet syndrome but mainly affects females. PLoS Genet, 5, 2009, e1000381.
10. 10 Marini, C., Darra, F., Specchio, N., et al. Focal seizures with affective symptoms are a major feature of PCDH19 gene–related epilepsy. Epilepsia 53 (2012), 2111–2119.
11. 11 Neul, J.L., Kaufmann, W.E., Glaze, D.G., et al. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 68 (2010), 944–949.
12. 12 Qu, M., Aronica, E., Boer, K., et al. DLG3/SAP102 protein expression in malformations of cortical development: a study of human epileptic cortex by tissue microarray. Epilepsy Res 84 (2009), 33–41.